{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:3731638e-186d-4843-b67f-ed30d12dca58","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T11:28:38.538719+00:00","published_at":"2026-10-17T04:46:47.349247+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:18c923xy9tlt3","event_type":"GC_CHANGED","effective_at":"2026-03-16","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:colin-g-sandercock","alpha:company:3731638e-186d-4843-b67f-ed30d12dca58"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:f2bdf35e890076f9f2a3f2f6f84355052fb69c6f42337463f00d1ad0dbd2de18"],"summary":"Colin G. Sandercock executive of Cue Biopharma, Inc., effective 2026-03-16.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:x9ihqj10byz8p","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-16","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:dean-baker","alpha:company:3731638e-186d-4843-b67f-ed30d12dca58"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:eaf99dd1aa5589b67b845e81ab128e8659000f4a69491c7b0b9e3102a9c9232e"],"summary":"Douglas G. Baker executive of Cue Biopharma, Inc., effective 2026-03-16.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ykhy614lnd4g","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-16","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:lucinda-warren","alpha:company:3731638e-186d-4843-b67f-ed30d12dca58"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:b6e883872219ad0914e20ee2f9be70862e3d2d522fddd466b231674b9e54182e"],"summary":"Lucinda Warren executive of Cue Biopharma, Inc., effective 2026-03-16.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:w3el04f84io","event_type":"CEO_CHANGED","effective_at":"2026-03-16","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:usman-azam","alpha:company:3731638e-186d-4843-b67f-ed30d12dca58"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:7d3f1d080fef62e8530fa46ff892f1aa18bd2ac7212e7d068210b46cb5c50710"],"summary":"Usman Azam executive of Cue Biopharma, Inc., effective 2026-03-16.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:pn5shof79oi8","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:jill-broadfoot","alpha:company:3731638e-186d-4843-b67f-ed30d12dca58"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3"],"summary":"Jill Broadfoot seat on Cue Biopharma, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:11hv6qqunruza","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:pasha-sarraf","alpha:company:3731638e-186d-4843-b67f-ed30d12dca58"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3"],"summary":"Pasha Sarraf seat on Cue Biopharma, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:hra8b618py3k6","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:usman-azam","alpha:company:3731638e-186d-4843-b67f-ed30d12dca58"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3"],"summary":"Usman Azam seat on Cue Biopharma, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:qle6q1orcwsk","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:committee:cue-biopharma-inc:audit-chair","alpha:company:3731638e-186d-4843-b67f-ed30d12dca58"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3"],"summary":"Audit · Chair committee of Cue Biopharma, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:l3awi2prn5cs","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:jill-broadfoot","alpha:committee:cue-biopharma-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3"],"summary":"Jill Broadfoot member of Audit · Chair, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:u8ywbt1an48yr","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:pamela-d-garzone","alpha:company:3731638e-186d-4843-b67f-ed30d12dca58"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3"],"summary":"Pamela D. Garzone seat on Cue Biopharma, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:i7gqo3hwh3sl","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:patrick-verheyen","alpha:company:3731638e-186d-4843-b67f-ed30d12dca58"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3"],"summary":"Patrick Verheyen seat on Cue Biopharma, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1bgn9in1dhxpyd","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:committee:cue-biopharma-inc:audit-compensation","alpha:company:3731638e-186d-4843-b67f-ed30d12dca58"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3"],"summary":"Audit; Compensation committee of Cue Biopharma, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:16d6pp28rqizk","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:patrick-verheyen","alpha:committee:cue-biopharma-inc:audit-compensation"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3"],"summary":"Patrick Verheyen member of Audit; Compensation, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:123n1i7256nw9","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:pamela-d-garzone","alpha:committee:cue-biopharma-inc:compensation"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:committee_record:19"],"evidence_ids":["alpha:projection-evidence:2b38a5c2d9f3b121533bc26f842a78462761bc26868ead5c745d9d62d5b6021c"],"summary":"Pamela D. Garzone member of Compensation, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1apnwultz3rwd","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:frank-morich","alpha:company:3731638e-186d-4843-b67f-ed30d12dca58"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3"],"summary":"Frank Morich seat on Cue Biopharma, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ti7ba77ylpjr","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:peter-a-kiener","alpha:company:3731638e-186d-4843-b67f-ed30d12dca58"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3"],"summary":"Peter A. Kiener seat on Cue Biopharma, Inc., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1818w2f2zbtrj","event_type":"COMMITTEE_CREATED","effective_at":"2016-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:committee:cue-biopharma-inc:compensation-chair","alpha:company:3731638e-186d-4843-b67f-ed30d12dca58"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3"],"summary":"Compensation · Chair committee of Cue Biopharma, Inc., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:zhsh261csspj2","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2016-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:peter-a-kiener","alpha:committee:cue-biopharma-inc:compensation-chair"],"caused_claim_ids":["alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3"],"summary":"Peter A. Kiener member of Compensation · Chair, effective 2016-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:5","subject_id":"alpha:company:3731638e-186d-4843-b67f-ed30d12dca58","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:frank-morich","object_label":"Frank Morich","object_source_name_forms":[],"value":"Frank Morich: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:frank-morich","name":"Frank Morich"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cue Biopharma, Inc. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:00.478+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:6","subject_id":"alpha:company:3731638e-186d-4843-b67f-ed30d12dca58","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jill-broadfoot","object_label":"Jill Broadfoot","object_source_name_forms":[],"value":"Jill Broadfoot: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jill-broadfoot","name":"Jill Broadfoot"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cue Biopharma, Inc. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:00.478+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:7","subject_id":"alpha:company:3731638e-186d-4843-b67f-ed30d12dca58","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:pamela-d-garzone","object_label":"Pamela D. Garzone","object_source_name_forms":[],"value":"Pamela D. Garzone: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:pamela-d-garzone","name":"Pamela D. Garzone"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cue Biopharma, Inc. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:00.478+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:8","subject_id":"alpha:company:3731638e-186d-4843-b67f-ed30d12dca58","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:pasha-sarraf","object_label":"Pasha Sarraf","object_source_name_forms":[],"value":"Pasha Sarraf: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:pasha-sarraf","name":"Pasha Sarraf"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cue Biopharma, Inc. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:00.478+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:9","subject_id":"alpha:company:3731638e-186d-4843-b67f-ed30d12dca58","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:patrick-verheyen","object_label":"Patrick Verheyen","object_source_name_forms":[],"value":"Patrick Verheyen: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:patrick-verheyen","name":"Patrick Verheyen"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cue Biopharma, Inc. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:00.478+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:10","subject_id":"alpha:company:3731638e-186d-4843-b67f-ed30d12dca58","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:peter-a-kiener","object_label":"Peter A. Kiener","object_source_name_forms":[],"value":"Peter A. Kiener: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:peter-a-kiener","name":"Peter A. Kiener"},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cue Biopharma, Inc. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:00.478+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:11","subject_id":"alpha:company:3731638e-186d-4843-b67f-ed30d12dca58","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:usman-azam","object_label":"Usman Azam","object_source_name_forms":[],"value":"Usman Azam: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:usman-azam","name":"Usman Azam"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cue Biopharma, Inc. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:00.478+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:12","subject_id":"alpha:company:3731638e-186d-4843-b67f-ed30d12dca58","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:colin-g-sandercock","object_label":"Colin G. Sandercock","object_source_name_forms":[],"value":"Colin G. Sandercock: Senior Vice President, General Counsel and Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:colin-g-sandercock","name":"Colin G. Sandercock"},"title":"Senior Vice President, General Counsel and Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-16","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:f2bdf35e890076f9f2a3f2f6f84355052fb69c6f42337463f00d1ad0dbd2de18","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CUE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16T00:00:00+00:00","retrieved_at":"2026-05-16T01:12:56.440666+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16T00:00:00+00:00","effective_from":"2026-03-16","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:13","subject_id":"alpha:company:3731638e-186d-4843-b67f-ed30d12dca58","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:dean-baker","object_label":"Douglas G. Baker","object_source_name_forms":[],"value":"Douglas G. Baker: Interim Chief Development Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:dean-baker","name":"Douglas G. Baker"},"title":"Interim Chief Development Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-16","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:eaf99dd1aa5589b67b845e81ab128e8659000f4a69491c7b0b9e3102a9c9232e","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CUE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16T00:00:00+00:00","retrieved_at":"2026-05-16T01:12:57.374448+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16T00:00:00+00:00","effective_from":"2026-03-16","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:14","subject_id":"alpha:company:3731638e-186d-4843-b67f-ed30d12dca58","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:lucinda-warren","object_label":"Lucinda Warren","object_source_name_forms":[],"value":"Lucinda Warren: Chief Financial and Business Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:lucinda-warren","name":"Lucinda Warren"},"title":"Chief Financial and Business Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-16","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:b6e883872219ad0914e20ee2f9be70862e3d2d522fddd466b231674b9e54182e","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CUE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16T00:00:00+00:00","retrieved_at":"2026-05-16T01:12:56.949354+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16T00:00:00+00:00","effective_from":"2026-03-16","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:15","subject_id":"alpha:company:3731638e-186d-4843-b67f-ed30d12dca58","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:usman-azam","object_label":"Usman Azam","object_source_name_forms":[],"value":"Usman Azam: President, Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:usman-azam","name":"Usman Azam"},"title":"President, Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-16","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:7d3f1d080fef62e8530fa46ff892f1aa18bd2ac7212e7d068210b46cb5c50710","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CUE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16T00:00:00+00:00","retrieved_at":"2026-05-16T01:12:55.947771+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16T00:00:00+00:00","effective_from":"2026-03-16","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:committee_record:19","subject_id":"alpha:company:3731638e-186d-4843-b67f-ed30d12dca58","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Peter A. Kiener; Members Peter A. Kiener (Chair); Pamela D. Garzone; Patrick Verheyen","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Peter A. Kiener","members":[{"display_name":"Peter A. Kiener","person_slug":"peter-a-kiener","is_chair":true},{"display_name":"Pamela D. Garzone","person_slug":"pamela-d-garzone","is_chair":false},{"display_name":"Patrick Verheyen","person_slug":"patrick-verheyen","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:2b38a5c2d9f3b121533bc26f842a78462761bc26868ead5c745d9d62d5b6021c","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cue Biopharma, Inc. DEF 14A 2026-03-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16","retrieved_at":"2026-04-25T00:11:00.478+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f2bdf35e890076f9f2a3f2f6f84355052fb69c6f42337463f00d1ad0dbd2de18","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CUE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16T00:00:00+00:00","retrieved_at":"2026-05-16T01:12:56.440666+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:eaf99dd1aa5589b67b845e81ab128e8659000f4a69491c7b0b9e3102a9c9232e","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CUE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16T00:00:00+00:00","retrieved_at":"2026-05-16T01:12:57.374448+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b6e883872219ad0914e20ee2f9be70862e3d2d522fddd466b231674b9e54182e","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CUE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16T00:00:00+00:00","retrieved_at":"2026-05-16T01:12:56.949354+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:7d3f1d080fef62e8530fa46ff892f1aa18bd2ac7212e7d068210b46cb5c50710","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CUE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":"2026-03-16T00:00:00+00:00","retrieved_at":"2026-05-16T01:12:55.947771+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:2b38a5c2d9f3b121533bc26f842a78462761bc26868ead5c745d9d62d5b6021c","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.842,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.882,"cross_source_agreement":0.75,"temporal_completeness":0.688},"diagnostics":{"published_claims":22,"factual_claims":22,"claims_with_linked_evidence":22,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":16,"temporal_claims_with_valid_from":11,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:47.349247+00:00","observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":"2026-10-17T04:46:47.349247+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":22,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/cue-biopharma-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}